MOLLY CONROY: Open Payments
NPI 1518558931 · FESTUS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,770 in 134 payments from 21 companies in 2025. Trend: 2023 $1,725 · 2024 $2,164 · 2025 $2,770
Food & beverage: $2,545Education: $225
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $493 |
| Janssen Biotech, Inc. | 23 | $385 |
| UCB, Inc. | 15 | $372 |
| PFIZER INC. | 8 | $216 |
| Arcutis Biotherapeutics, Inc. | 19 | $187 |
| Galderma Laboratories, L.P. | 7 | $173 |
| Lilly USA, LLC | 9 | $147 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $144 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 2 | $100 |
| Regeneron Healthcare Solutions, Inc. | 1 | $81 |
Products named: TREMFYA, Bimzelx, RINVOQ, CIBINQO, SKYRIZI, Zoryve, NEMLUVIO, TALTZ.
Industry payments across MO — which companies pay providers there.
